Clinical Trial Update: Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating bendamustine for acute lymphoblastic leukemia and lymphoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: WITHDRAWN